These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7050180)

  • 21. Comparative effects of prenalterol and dobutamine in a canine model of acute ischemic heart failure.
    Kirlin PC; Pitt B; Lucchesi BR
    J Cardiovasc Pharmacol; 1981; 3(4):896-905. PubMed ID: 6167819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological and clinical effects of prenalterol--a new inotropic beta-adrenoceptor stimulant. Proceedings of a symposium in Hamburg, December 5, 1980.
    Acta Med Scand Suppl; 1982; 659():1-325. PubMed ID: 6127881
    [No Abstract]   [Full Text] [Related]  

  • 23. Haemodynamic effects, plasma concentrations and tolerance of orally administered prenalterol in man.
    Weiss A; Pfister B; Imhof P; Degen PH; Burckhardt D; Dubach UC
    Eur J Clin Pharmacol; 1980 Nov; 18(5):383-90. PubMed ID: 6108221
    [No Abstract]   [Full Text] [Related]  

  • 24. Hemodynamic actions of prenalterol in severe congestive heart failure due to chronic coronary disease.
    Awan NA; Needham KE; Evenson MK; Win A; Mason DT
    Am Heart J; 1981 Feb; 101(2):158-61. PubMed ID: 7468416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Echocardiographic measurements of hemodynamic effects and pharmacokinetics of prenalterol (author's transl)].
    Oltmanns D; Wester HA; Stein R
    Z Kardiol; 1981 May; 70(5):394-8. PubMed ID: 6115520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical use of inotropes in cardiac failure: dopamine, dobutamine, prenalterol and pirbuterol.
    Rae AP; Tweddel AC; Hutton I
    Herz; 1983 Feb; 8(1):23-33. PubMed ID: 6832690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-cardiogenic pulmonary oedema. A serious complication of transurethral prostatectomy. A case report.
    Reiz S; Duchek M; Kerkoff Y; Olson B
    Acta Anaesthesiol Scand; 1981 Apr; 25(2):166-8. PubMed ID: 7324825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenalterol as a selective cardiostimulant: differences between organ and receptor selectivity.
    Kenakin TP
    J Cardiovasc Pharmacol; 1985; 7(1):208-10. PubMed ID: 2580145
    [No Abstract]   [Full Text] [Related]  

  • 29. Inotropic drugs of the future.
    Pouleur H; Detry JM; Mancia G
    Eur J Clin Invest; 1982 Dec; 12(6):441-3. PubMed ID: 6217976
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardioselectivity of prenalterol and isoproterenol.
    Jennings G; Bobik A; Oddie C; Hargreaves M; Korner P
    Clin Pharmacol Ther; 1983 Dec; 34(6):749-57. PubMed ID: 6641090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Echocardiographic comparison between prenalterol and dobutamine.
    Wester HA; Oltmanns D
    Acta Med Scand Suppl; 1982; 659():181-90. PubMed ID: 6127888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Electrophysiologic effects of prenalterol On sinus function in coronary disease patients].
    Bolognesi R; Cucchini F; Giacometti P; Sartori M; Zeppellini R; Javernaro A; Potenza D
    Cardiologia; 1982; 27(2):219-22. PubMed ID: 6927435
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of intravenous prenalterol on ventricular performance, as assessed by radionuclide ventriculography, in patients with ischaemic heart disease.
    Muir AL; Hannan WJ; Dewhurst NG; Slessor IM
    Br J Clin Pharmacol; 1981 Oct; 12(4):475-80. PubMed ID: 7295483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
    Erbel R; Meyer J; Schweizer P; Lambertz H; Voelker W; Effert S
    Acta Med Scand Suppl; 1982; 659():169-80. PubMed ID: 6127887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemodynamic effects of prenalterol in patients on dialysis.
    Lustenberger N
    Acta Med Scand Suppl; 1982; 659():157-67. PubMed ID: 6127886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Positive inotropic agents. Generalities and classification].
    Vahanian A; Le Potier J; Sergent J; Michel PL; Acar J
    Ann Med Interne (Paris); 1985; 136(3):242-6. PubMed ID: 2862822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immediate haemodynamic and electrophysiological response to prenalterol during fixed rate pacing in patients with chronic ischaemic heart disease.
    Sire S; Amlie JP; Simonsen S
    Acta Pharmacol Toxicol (Copenh); 1986 Jan; 58(1):43-8. PubMed ID: 3953293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic and haemodynamic effects and pharmacokinetics of a new selective beta 1-adrenoceptor agonist, prenalterol, in man.
    Rönn O; Fellenius E; Graffner C; Johnsson G; Lundborg P; Svensson L
    Eur J Clin Pharmacol; 1980 Feb; 17(2):81-6. PubMed ID: 6102914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardioselectivity of dobutamine and prenalterol in the pentobarbital anesthetized dog.
    Strosberg AM; Montgomery W
    Proc West Pharmacol Soc; 1981; 24():83-7. PubMed ID: 7255492
    [No Abstract]   [Full Text] [Related]  

  • 40. The haemodynamic effects of intravenous prenalterol and ouabain in conscious dogs.
    Ek L; Björkman JA; Carlsson E; Johansson B
    Acta Med Scand Suppl; 1982; 659():39-52. PubMed ID: 6127899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.